California’s Division of Workers’ Compensation (DWC) issued an update to the Physician and Non-Physician Practitioner portion of the Official Medical Fee Schedule (OMFS) for workers’ compensation, effective for all dates of service on or after October 1, 2024.
The update adds 32 new procedure codes.
The update conforms the OMFS to relevant 2024 Medicare payment system changes, as the California Labor Code requires. The DWC announced the update in a recent Newsline, and posted the order adopting the update on the DWC website.
daisyBIll clients do not need to take any action. We added the new HCPCS to our billing software, which will automatically apply the changes for all dates of service on or after October 1.
Non-daisyBill providers are advised to adjust their systems for dates of services starting October 1.
Read on for details!
The update aligns the OMFS to relevant 2024 changes in the Medicare payment system, as required by California Labor Code Section 5307.1.
Below are the 32 new Healthcare Common Procedure Coding System (HCPCS) codes adopted by the DWC (and CMS) for Q4 2024.
Note that when Medicare fails to assign an HCPCS code a Relative Value Unit (RVU), the reimbursement is calculated “By Report” (BR). California Code of Regulations Section 9789.12.4 provides guidelines for appropriate reimbursement amounts for BR codes.
HCPCS |
Description |
Reimbursement Calculation |
90624 |
Menb-4c&menacwy vacc im |
By Report |
90684 |
Pcv21 vaccine im |
By Report |
A9610 |
Xe129 xenon, diagnostic |
By Report |
J0138 |
Injection, acetaminoph 10 mg |
By Report |
J0175 |
Inj, donanemab-azbt, 2 mg |
By Report |
J1171 |
Inj, hydromorphone, 0.1 mg |
By Report |
J1749 |
Inj, iloprost, 0.1 mcg |
By Report |
J2002 |
Inj, lidocaine in d5w, 1 mg |
By Report |
J2003 |
Inj, lidocaine hcl, 1 mg |
By Report |
J2004 |
Inj, lidocaine w epinephrine |
By Report |
J2252 |
Inj midazolam in 0.8% nacl |
By Report |
J2253 |
Inj midazolam (seizalam) |
By Report |
J2601 |
Inj, vasopressin (baxter) |
By Report |
J8522 |
Capecitabine, oral, 50 mg |
By Report |
J8541 |
Oral, hemady, 0.25 mg |
By Report |
J9329 |
Inj, tislelizumab-jsgr |
By Report |
Q0519 |
Supply fee hiv prep inj 30 |
By Report |
Q0520 |
Supply fee hiv prep inj 60 |
By Report |
Q4334 |
Amnioplast 1, per sq cm |
By Report |
Q4335 |
Amnioplast 2, per sq cm |
By Report |
Q4336 |
Artecent c, per sq cm |
By Report |
Q4337 |
Artecent trident, per sq cm |
By Report |
Q4338 |
Artacent velos, per sq cm |
By Report |
Q4339 |
Artacent vericlen, per sq cm |
By Report |
Q4340 |
Simpligraft, per sq cm |
By Report |
Q4341 |
Simplimax, per sq cm |
By Report |
Q4342 |
Theramend, per sq cm |
By Report |
Q4343 |
Dermacyte ac matrx per sq cm |
By Report |
Q4344 |
Tri membrane wrap, per sq cm |
By Report |
Q4345 |
Matrix hd allogrft per sq cm |
By Report |
Q5135 |
Inj, tyenne, 1 mg |
By Report |
Q5136 |
Inj. denosumab-bbdz, 1 mg |
By Report |
Again, bills submitted via daisyBill will automatically reflect the most current, accurate reimbursement rates. If you have any questions regarding this fee schedule update, use the chat function at the bottom right of this screen or email our experts at info@daisybill.com.
DaisyBill provides content as an insightful service to its readers and clients. It does not offer legal advice and cannot guarantee the accuracy or suitability of its content for a particular purpose.